Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment.

ABSTRACT:

Importance

Head and neck cancer (HNC) and its treatment may negatively alter neurocognitive and speech functioning. However, the prevalence of neurocognitive impairment among patients with HNC before treatment is poorly studied, and the association between neurocognitive and speech functioning is unknown, which hampers good interpretability of the effect of HNC treatment on neurocognitive and speech function.

Objectives

To document neurocognitive functioning in patients with HNC before treatment and to investigate the association between neurocognitive and speech functioning.

Design, setting, and participants

Prospective cohort study of newly diagnosed patients with HNC before treatment using a large sample obtained in a nationwide, multicenter setting (Netherlands Qu

SUBMITTER: Piai V 

PROVIDER: S-EPMC6439757 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature